GlaxoSmithKline

Company Score

+0.18
Industry Pharmaceuticals
Country United Kingdom
Year Added 2018
Impact Ratings 709
Impact Notes 23
SDG Covered 8 out of 17

GSK is a global healthcare company, researching and developing products for its three main arms of business - pharmaceuticals, vaccines and consumer health care. It is a British multinational company with a head office based in London.

Its top-selling products are Advair, Avodart, Flovent, Augmentin, Lovaza and Lamictal. Well recognised consumer products include Sensodyne and Aquafresh toothpaste, Horlicks, Nicorette and Night Nurse. Its pharma business develops and sells drugs for the treatment of acute illnesses and diseases, and the vaccination arm develops vaccinations. GSK currently delivers over 2 million vaccine doses per day in 160 countries. The World Health Organization 'Model List of Essential Medicines', feature many of GSK legacy products such as amoxicillin, mercaptopurine, and pyrimethamine.

Read about GlaxoSmithKline and its impact below.

Impact notes

Good Health and Well-being

GSK'S Nelarabine costs USD33,600 per month, putting undue financial burden on cancer patients

Profile Manisha Rao
Icon time Mon May 31st, 2021 at 2:32pm

Over 800 Mn people spend a minimum of 10% of their household budget on healthcare, and 100 Mn people end up in extreme poverty due to unaffordable out-of-pocket (OOP costs) health expenses1. Blood cancer care is expensive to the healthcare system. In the first year following the patient's diagnosis, the average annual allowed spending for treating blood cancer is $156,000, and the high expenses continue beyond the first year 3:p2. About 12% of cancer patients lowered the dose of prescription drugs to make them last longer7. Leukemia & Lymphoma are the most common blood cancer4, accounting for over one million new cases and 573,725 deaths worldwide in 20202

Good Health and Well-being

GSK, 10 billion pills donated (and counting) to address neglected diseases.

Profile Guillaume Krepper
Icon time Fri Mar 5th, 2021 at 9:20am

Nearly 30% of the world's population (2 bn people) lack access to basic healthcare services1. Further, impacted people are predominantly living in low and middle-income countries where demographic growth is the strongest2;p.1, thus increasing the scale of the challenge.

Gender Equality

Guided by its female CEO, GSK is the right way to eradicate gender inequality in its workforce.

Profile Citaugu
Icon time Wed Feb 24th, 2021 at 8:27am

Women accounted for 70% of the world's total health care workers in 20191;p3. Women tend to be part-time employees more likely than men. Globally, in health care, the pay gap between men and women was 11.2% in 20191;p3. The Inclusion of women in healthcare is more important because women make up 80% of decision-makers in using medicines at home3.  

Good Health and Well-being

GlaxoSmithKline donated USD 360 Mn in 2019 for community health programs

Profile Nadia Hussain
Icon time Tue Feb 9th, 2021 at 12:14pm

According to the World Health Organisation approximately 2 Bn people lack access to basic medicines1. About 80% of the global population lives in countries where access to controlled medicines that are used for relieving moderate pains is zero or minute2;p15. Worldwide, about 100 Mn people end up in extreme poverty due to out of pocket health expenses3.

Clean Water and Sanitation

GlaxoSmithKline  discharged 9.9 Mn m3 of wastewater in FY2019

Profile Nadia Hussain
Icon time Tue Feb 9th, 2021 at 10:34am

The UN has stated that 80% of global discharged wastewater returns into the environment without being properly treated2In the pharmaceutical industry, approximately half of the wastewater produced is discharged without proper treatment1. A major wastewater source in the pharmaceutical industry comes from washing and cleaning equipment in various manufacturing plants after each batch of medicines3;p4.